A Study of Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients
Clinical trial NCT00849875 · TERMINATED
Trial details
- NCT number
- NCT00849875
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-26
- Primary completion
- 2014-11-17
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.